Kaya Holdings (KAYS) EBITDA (2011 - 2025)
Kaya Holdings (KAYS) recorded quarterly EBITDA of -$269010.0 in Q3 2025, down 65.46% quarter-over-quarter from -$162584.0 in Q2 2025, and up 74.2% on a YoY basis from -$154424.0 in Q3 2024.
Kaya Holdings (KAYS) EBITDA (2011 - 2025) Analysis & Trends
Kaya Holdings' EBITDA history runs 15 years deep, the most recent figure standing at -$269010.0 for Q3 2025.
- In Q3 2025, EBITDA rose 74.2% year-over-year to -$269010.0; the TTM figure through Sep 2025 stood at -$1.1 million (up 33.65% YoY), while the FY2024 annual figure was -$2.0 million, down 97.71% from the prior year.
- EBITDA was -$269010.0 for Q3 2025 at Kaya Holdings, down from -$162584.0 in the prior quarter.
- In the past five years, EBITDA ranged from a high of -$97424.0 in Q4 2023 to a low of -$1.0 million in Q3 2024.
- Historically, EBITDA has averaged -$364588.8 across 5 years, with a median of -$309538.0 in 2025.
- The sharpest annual moves came in 2023 and 2024: EBITDA soared 88.44% in 2023, then tumbled 310.44% in 2024.
- A 5-year view of EBITDA shows it stood at -$374913.0 in 2021, then sank by 124.88% to -$843113.0 in 2022, then jumped by 88.44% to -$97424.0 in 2023, then sank by 310.44% to -$399863.0 in 2024, then surged by 32.72% to -$269010.0 in 2025.
- The last three EBITDA figures came in at -$269010.0 (Q3 2025), -$162584.0 (Q2 2025), and -$309538.0 (Q1 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.34 Bn | 34.60 Bn | 1.97 Bn | 652.00 Mn |
| 2 | Zoetis | 33.27 Bn | 31.33 Bn | 1.62 Bn | 833.00 Mn |
| 3 | United Therapeutics | 23.75 Bn | 21.60 Bn | 648.10 Mn | 325.80 Mn |
| 4 | Aurora Cannabis | 17.11 Bn | 17.03 Bn | 33.43 Mn | -681,231.97 |
| 5 | Neurocrine Biosciences | 16.37 Bn | 15.05 Bn | 800.70 Mn | 185.20 Mn |
| 6 | Elanco Animal Health | 11.78 Bn | 11.35 Bn | 785.00 Mn | 307.00 Mn |
| 7 | Alkermes | 7.05 Bn | 6.54 Bn | -116.06 Mn | -67.29 Mn |
| 8 | Lantheus Holdings | 6.49 Bn | 5.99 Bn | 230.92 Mn | 81.33 Mn |
| 9 | Hims & Hers Health | 6.19 Bn | 5.44 Bn | 396.79 Mn | -98.81 Mn |
| 10 | Kaya Holdings | - | - | 5,370.00 | -269,010.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | -269,010.00 |
| Jun 30, 2025 | -162,584.00 |
| Mar 31, 2025 | -309,538.00 |
| Dec 31, 2024 | -399,863.00 |
| Sep 30, 2024 | -1.04 Mn |
| Jun 30, 2024 | -340,573.00 |
| Mar 31, 2024 | -238,830.00 |
| Dec 31, 2023 | -97,424.00 |
| Sep 30, 2023 | -276,130.00 |
| Jun 30, 2023 | -313,313.00 |
| Mar 31, 2023 | -335,878.00 |
| Dec 31, 2022 | -843,113.00 |
| Sep 30, 2022 | -269,864.00 |
| Jun 30, 2022 | -269,519.00 |
| Mar 31, 2022 | -328,944.00 |
| Dec 31, 2021 | -374,913.00 |
| Sep 30, 2021 | -473,158.00 |
| Jun 30, 2021 | -284,299.00 |
| Mar 31, 2021 | -297,472.00 |
| Dec 31, 2020 | -477,437.00 |